Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen‐Dependent Bone Loss in Mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen‐Dependent Bone Loss in Mice
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-14
DOI
10.1002/jbmr.4025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
- (2018) Sarah Weske et al. NATURE MEDICINE
- Marine Natural Products in Medicinal Chemistry
- (2018) Carlos Jiménez ACS Medicinal Chemistry Letters
- Marine Pharmacology in 2012–2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action
- (2017) Alejandro Mayer et al. Marine Drugs
- Screening a Natural Product-Based Library against Kinetoplastid Parasites
- (2017) Bilal Zulfiqar et al. MOLECULES
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triptolide inhibits the function of TNF-α in osteoblast differentiation by inhibiting the NF-κB signaling pathway
- (2017) Shen-Peng Liu et al. Experimental and Therapeutic Medicine
- Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway
- (2017) Mengrui Wu et al. Nature Communications
- LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
- (2016) Jian Luo et al. NATURE MEDICINE
- Ablation of Y1 receptor impairs osteoclast bone-resorbing activity
- (2016) Daniela M. Sousa et al. Scientific Reports
- Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation
- (2015) Xiaoqin Fan et al. Scientific Reports
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors
- (2013) A. Gabrielle J. van der Kraan et al. BIOCHEMICAL JOURNAL
- Andrographolide suppresses RANKL-induced osteoclastogenesisin vitroand prevents inflammatory bone lossin vivo
- (2013) Z J Zhai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Marine Bioactives: Pharmacological Properties and Potential Applications against Inflammatory Diseases
- (2012) Nicolantonio D’Orazio et al. Marine Drugs
- Akt Induces Osteoclast Differentiation through Regulating the GSK3 /NFATc1 Signaling Cascade
- (2011) J. B. Moon et al. JOURNAL OF IMMUNOLOGY
- Structural Features Underlying Selective Inhibition of GSK3β by Dibromocantharelline: Implications for Rational Drug Design
- (2010) Na Zhang et al. Chemical Biology & Drug Design
- Signaling networks in RUNX2-dependent bone development
- (2010) Toshihisa Komori JOURNAL OF CELLULAR BIOCHEMISTRY
- Preparation of Hymenialdisine, Analogues and Their Evaluation as Kinase Inhibitors
- (2009) T. Nguyen et al. CURRENT MEDICINAL CHEMISTRY
- Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
- (2009) Takako Negishi-Koga et al. IMMUNOLOGICAL REVIEWS
- BMP-2 modulates β-catenin signaling through stimulation ofLrp5expression and inhibition of β-TrCP expression in osteoblasts
- (2009) Ming Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- GSK3: a multifaceted kinase in Wnt signaling
- (2009) Dianqing Wu et al. TRENDS IN BIOCHEMICAL SCIENCES
- PU.1 and NFATc1 mediate osteoclastic induction of the mouse β3 integrin promoter
- (2008) Tania N. Crotti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis
- (2008) Keith D Brown et al. ARTHRITIS RESEARCH & THERAPY
- Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases
- (2007) Nobuo Suzuki et al. JOURNAL OF PINEAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started